Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0022, a Novel MET/CSF1R/SRC Inhibitor

World News: . []

SAN DIEGO May 15 2019 GLOBE NEWSWIRE -- Turning Point Therapeutics Inc LINK  TPTX a precision oncology LINK  developing novel drugs that address treatment resistance today LINK  clearance by theUS Food and Drug Administration (FDA) ...

More news and information about Turning Point Therapeutics, Inc.

Published By:

Globe Newswire: 14:00 GMT Wednesday 15th May 2019

Published: .

Search for other references to "turning" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us